Association of Stage of Breast Cancer Diagnosis and Socioeconomic Status in French Women

Conference Correspondent  - ASCO 2021 - Breast Cancer

Socioeconomic deprivation is commonly used to study the effects of deprivation and poverty on healthcare. Although breast cancer is known to be linked to socioeconomic deprivation and living in rural areas, the relationship between occurrence of breast cancer diagnosis and socioeconomic conditions is not clearly understood.

Investigators examined the correlation between diagnosis of early- and late-stage breast cancer and socioeconomic background in 14,542 French women. Socioeconomic status was determined by location of residence and information from the European Deprivation Index, which was used to create 4 categories: affluent-urban, affluent-rural, deprived-urban, and deprived-rural. Compared with the affluent-urban group, women whose socioeconomic status was deprived-rural had an increased diagnosis of advanced-stage breast cancer and lower frequency of early-stage breast cancer at <74 years of age. Associations by breast cancer stage were not present for women aged >74 years.

The results of the study suggest late-stage diagnosis is most likely associated with women aged ≤74 years with deprived-rural socioeconomic background. The results did not reveal any disparities in the incidence rates of advanced breast cancer based on socioeconomic background in any age class.

Source: Ariza JM, Cowppli-Bony A, Billon S, et al. Socioeconomic background in relation to stage at diagnosis in women with breast cancer. American Society of Clinical Oncology Virtual Meeting; June 4-8, 2021. Abstract 10574.

Related Items
Inflammatory Responses to Neoadjuvant Chemotherapy Can Be Regulated by Moderate Physical Exercise Prior to Surgery
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Assessment of Factors That Influence Psychosocial Function in Breast Cancer Patients After Treatment
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Identification of Biomarkers for HER2-Negative Advanced Breast Cancer Is Influenced by Race: A Real-World Study
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Treatment with Alpelisib plus Fulvestrant Achieves Long-Term Disease Control in Endocrine-Resistant (HR-Positive/HER2-Negative) Advanced Breast Cancer
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Behavioral Interventions Demonstrate Improved Long-Term Adherence to Adjuvant Endocrine Therapy Among Women with HR-Positive Breast Cancer
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Assessment of Oncology Patient Satisfaction with Telehealth Visits
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Need for Improved Access to Cancer Screening Tools for Minorities with Socioeconomic Barriers to Medical Care
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Novel and Clinically Relevant Measure of Perceived Fatigability Reveals Benefit of Exercise in Breast Cancer Survivors
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Alpelisib Overcomes Resistance to CDK4/6 Inhibitors in HR-Positive/HER2-Negative Advanced Breast Cancer Patients
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Demographic and Clinical Factors Among Women with Breast Cancer Create a Gap Between Referrals and Completion of Genetic Counseling and Testing
Conference Correspondent  published on June 4, 2021 in ASCO 2021 - Breast Cancer
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.